Skip to main content

Cardiol Therapeutics Inc(CRDL-T)
TSX

Today's Change
Real-Time Last Update
Volume

Cardiol Therapeutics Inc

2265 Upper Middle Road East
Suite 602
Oakville ON L6H 0G5 CAN
P: 289-910-0850
https://www.cardiolrx.com

Sectors & Indices

Sector
Industry
Employees

Profile

Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in Phase II/III study, the LANCER trial. The CardiolRx is also being investigated in patients with acute myocarditis and recurrent pericarditis.

Key Executives

NameTitle
Christopher J. WaddickCFO/Secretary
David G. ElsleyCEO/Director/President
Andrew HamerChief Medical Officer
Bernard LimCOO